177 related articles for article (PubMed ID: 18258741)
1. The same mutation in Gsalpha and transducin alpha reveals behavioral differences between these highly homologous G protein alpha-subunits.
Zurita AR; Birnbaumer L
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2363-8. PubMed ID: 18258741
[TBL] [Abstract][Full Text] [Related]
2. Mutation R238E in transducin-alpha yields a GTPase and effector-deficient, but not dominant-negative, G-protein alpha-subunit.
Barren B; Natochin M; Artemyev NO
Mol Vis; 2006 May; 12():492-8. PubMed ID: 16735989
[TBL] [Abstract][Full Text] [Related]
3. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK
J Biol Chem; 1998 Feb; 273(9):5109-16. PubMed ID: 9478963
[TBL] [Abstract][Full Text] [Related]
4. Coupling between the N- and C-terminal domains influences transducin-alpha intrinsic GDP/GTP exchange.
Muradov KG; Artemyev NO
Biochemistry; 2000 Apr; 39(14):3937-42. PubMed ID: 10747781
[TBL] [Abstract][Full Text] [Related]
5. Mutagenesis in the switch IV of the helical domain of the human Gsalpha reduces its GDP/GTP exchange rate.
Echeverría V; Hinrichs MV; Torrejón M; Ropero S; Martinez J; Toro MJ; Olate J
J Cell Biochem; 2000 Jan; 76(3):368-75. PubMed ID: 10649434
[TBL] [Abstract][Full Text] [Related]
6. A switch 3 point mutation in the alpha subunit of transducin yields a unique dominant-negative inhibitor.
Pereira R; Cerione RA
J Biol Chem; 2005 Oct; 280(42):35696-703. PubMed ID: 16103122
[TBL] [Abstract][Full Text] [Related]
7. Restricting mobility of Gsalpha relative to the beta2-adrenoceptor enhances adenylate cyclase activity by reducing Gsalpha GTPase activity.
Wenzel-Seifert K; Lee TW; Seifert R; Kobilka BK
Biochem J; 1998 Sep; 334 ( Pt 3)(Pt 3):519-24. PubMed ID: 9729456
[TBL] [Abstract][Full Text] [Related]
8. Examining the efficiency of receptor/G-protein coupling with a cleavable beta2-adrenoceptor-gsalpha fusion protein.
Seifert R; Wenzel-Seifert K; Gether U; Lam VT; Kobilka BK
Eur J Biochem; 1999 Mar; 260(3):661-6. PubMed ID: 10102993
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of the adenylyl cyclase activator Gsalpha.
Sunahara RK; Tesmer JJ; Gilman AG; Sprang SR
Science; 1997 Dec; 278(5345):1943-7. PubMed ID: 9395396
[TBL] [Abstract][Full Text] [Related]
10. A novel mutation in the switch 3 region of Gsalpha in a patient with Albright hereditary osteodystrophy impairs GDP binding and receptor activation.
Warner DR; Weng G; Yu S; Matalon R; Weinstein LS
J Biol Chem; 1998 Sep; 273(37):23976-83. PubMed ID: 9727013
[TBL] [Abstract][Full Text] [Related]
11. Mutation of the highly conserved Arg165 and Glu168 residues of human Gsalpha disrupts the alphaD-alphaE loop and enhances basal GDP/GTP exchange rate.
Hinrichs MV; Montecino M; Bunster M; Olate J
J Cell Biochem; 2004 Oct; 93(2):409-17. PubMed ID: 15368366
[TBL] [Abstract][Full Text] [Related]
12. Substitution of transducin ser202 by asp abolishes G-protein/RGS interaction.
Natochin M; Artemyev NO
J Biol Chem; 1998 Feb; 273(8):4300-3. PubMed ID: 9468476
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis of the conserved residue Glu259 of Gsalpha demonstrates the importance of interactions between switches 2 and 3 for activation.
Warner DR; Romanowski R; Yu S; Weinstein LS
J Biol Chem; 1999 Feb; 274(8):4977-84. PubMed ID: 9988742
[TBL] [Abstract][Full Text] [Related]
14. Stabilization of an intermediate activation state for transducin by a fluorescent GTP analogue.
Ramachandran S; Cerione RA
Biochemistry; 2004 Jul; 43(27):8778-86. PubMed ID: 15236586
[TBL] [Abstract][Full Text] [Related]
15. Rhodopsin recognition by mutant G(s)alpha containing C-terminal residues of transducin.
Natochin M; Muradov KG; McEntaffer RL; Artemyev NO
J Biol Chem; 2000 Jan; 275(4):2669-75. PubMed ID: 10644728
[TBL] [Abstract][Full Text] [Related]
16. Different effects of Gsalpha splice variants on beta2-adrenoreceptor-mediated signaling. The Beta2-adrenoreceptor coupled to the long splice variant of Gsalpha has properties of a constitutively active receptor.
Seifert R; Wenzel-Seifert K; Lee TW; Gether U; Sanders-Bush E; Kobilka BK
J Biol Chem; 1998 May; 273(18):5109-16. PubMed ID: 9556548
[TBL] [Abstract][Full Text] [Related]
17. Gain-of-function screen of α-transducin identifies an essential phenylalanine residue necessary for full effector activation.
Milano SK; Wang C; Erickson JW; Cerione RA; Ramachandran S
J Biol Chem; 2018 Nov; 293(46):17941-17952. PubMed ID: 30266806
[TBL] [Abstract][Full Text] [Related]
18. Identification of amino acid residues of Gsalpha critical to repression of adipogenesis.
Liu X; Malbon CC; Wang HY
J Biol Chem; 1998 May; 273(19):11685-94. PubMed ID: 9565589
[TBL] [Abstract][Full Text] [Related]
19. Facilitation of signal onset and termination by adenylyl cyclase.
Scholich K; Mullenix JB; Wittpoth C; Poppleton HM; Pierre SC; Lindorfer MA; Garrison JC; Patel TB
Science; 1999 Feb; 283(5406):1328-31. PubMed ID: 10037603
[TBL] [Abstract][Full Text] [Related]
20. S111N mutation in the helical domain of human Gs(alpha) reduces its GDP/GTP exchange rate.
Brito M; Guzmán L; Romo X; Soto X; Hinrichs MV; Olate J
J Cell Biochem; 2002; 85(3):615-20. PubMed ID: 11968001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
